Literature DB >> 12133262

Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women.

Gwen van Servellen1, Betty Chang, Lorraine Garcia, Emilia Lombardi.   

Abstract

Antiretroviral treatment nonadherence is complex, implicating more than a patient's ability and motivation to be compliant. The bulk of the research to date focuses on individual level barriers with less emphasis on the many system level factors that potentially impact patients' adherence behaviors. This study examined the effects of system enabling factors in addition to the frequently studied individual predisposing and enabling factors upon nonadherence to treatment. One hundred eighty-two patients from five community-based clinics were interviewed and their medical charts examined. Patients' self-reported nonadherence was correlated with clinicians' assessments of medication and appointment nonadherence. Seven individual predisposing factors (gender, ethnicity, birthplace, years of education, HIV Overview of Problems-Evaluation System [HOPES] psychosocial, Hospital Anxiety and Depression Scale [HADS] anxiety, and HADS depression scores) were found to be significantly associated with treatment adherence/nonadherence. Individual enabling factors (hopefulness and access to health care), as well as treatment by clinic staff, a system enabling factor, were significantly associated with adherence/nonadherence. In a multivariate analysis, six factors - age (younger), gender (female), birth outside the United States, level of hopefulness (lower), access to health care (lower), and treatment by clinic staff (poorer) - accounted for 19.3% of the variance in nonadherence. Results of this study indicated that several individual predisposing and enabling factors were potential predictors of treatment nonadherence; however, system enabling factors, e.g., treatment by clinic staff were also associated with treatment nonadherence. Further studies are needed to examine the complex relationships of individual and system related factors in predicting treatment nonadherence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133262     DOI: 10.1089/10872910260066705

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  24 in total

1.  Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection.

Authors:  Wen-Sy Tsai; Pao-Shiu Hsieh; Chien-Yuh Yeh; Jy-Ming Chiang; Reiping Tang; Jinn-Shiun Chen; Chung Rong Changchien; Jeng Yi Wang
Journal:  Int J Clin Oncol       Date:  2012-01-20       Impact factor: 3.402

Review 2.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

Review 3.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

Authors:  J S Atkinson; L Nilsson Schönnesson; M L Williams; S C Timpson
Journal:  AIDS Care       Date:  2008-02

6.  Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.

Authors:  Moupali Das-Douglas; Elise D Riley; Kathleen Ragland; David Guzman; Richard Clark; Margot B Kushel; David R Bangsberg
Journal:  AIDS Behav       Date:  2008-05-16

Review 7.  Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.

Authors:  Olalekan A Uthman; Jessica F Magidson; Steven A Safren; Jean B Nachega
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

8.  A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

Authors:  Charles P Brandt; Daniel J Paulus; Monica Garza; Chad Lemaire; Peter J Norton; Michael J Zvolensky
Journal:  Cogn Behav Pract       Date:  2017-03-02

9.  Baseline patient characteristics and mortality associated with longitudinal intervention compliance.

Authors:  Julia Y Lin; Thomas R Ten Have; Hillary R Bogner; Michael R Elliott
Journal:  Stat Med       Date:  2007-12-10       Impact factor: 2.373

10.  Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.

Authors:  John C Chalker; Tenaw Andualem; Lillian N Gitau; Joseph Ntaganira; Celestino Obua; Hailu Tadeg; Paul Waako; Dennis Ross-Degnan
Journal:  BMC Health Serv Res       Date:  2010-02-19       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.